{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:19:33Z","timestamp":1783948773647,"version":"3.55.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Recurrent urolithiasis causes substantial healthcare and economic burden due to high recurrence rates and need for repeated interventions. Potassium citrate effectively prevents stone recurrence, yet its cost-effectiveness compared with nontreatment remains unclear. We aimed to evaluate the economic impact of potassium citrate therapy in the prevention and management of urolithiasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A structured narrative review was conducted to evaluate the economic impact of potassium citrate therapy in urolithiasis. Databases were searched for studies assessing costs, cost-effectiveness, or healthcare resource utilization related to potassium citrate. Due to substantial heterogeneity in analytic perspective, outcomes, time horizons, and healthcare system context, findings were synthesized narratively rather than quantitatively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The economic evidence base was limited but consistent in demonstrating a meaningful reduction in stone recurrence with potassium citrate therapy. Two decision-analytic economic evaluations showed that potassium citrate substantially lowers recurrence rates compared with conservative management, translating into reduced downstream healthcare utilization. Economic outcomes were most favorable in patients with high baseline recurrence risk and in healthcare systems with lower medication acquisition costs. Across models, recurrence risk, drug pricing, and treatment adherence emerged as clear and reproducible drivers of economic value. No studies incorporated quality-adjusted life years or health utility outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Potassium citrate is a clinically effective and economically reasonable preventive therapy for recurrent urolithiasis, particularly in high-risk and hypocitraturic patients. When targeted to appropriate populations, it reduces recurrence and can offset downstream treatment costs. The current evidence supports potassium citrate as a key component of preventive stone management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ua.ua_37_26","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:00:15Z","timestamp":1783947615000},"page":"199-205","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Economic impact of potassium citrate in urolithiasis: A narrative review and economic evidence synthesis"],"prefix":"10.4103","volume":"18","author":[{"given":"Arianna","family":"Pischetola","sequence":"first","affiliation":[{"name":"Department of Urology, Faculty of Medicine, University Campus Bio-Medico of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Talyshinskii","sequence":"additional","affiliation":[{"name":"Department of Urology, Genome Clinic, Astana, Kazakhstan"},{"name":"Department of Urology, Central Asian Medical University, Fergana, Uzbekistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wissam","family":"Kamal","sequence":"additional","affiliation":[{"name":"Department of Urology, Urology Unit, King Fahd General Hospital, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar K.","family":"Somani","sequence":"additional","affiliation":[{"name":"Department of Urology, University Hospital Southampton, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"R1-20260713","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/end.2024.0673","article-title":"Economic burden of imaging and interventions in endourology: A worldwide cost analysis from European Association of Urology Young Academic Urology Endourology and Urolithiasis working party","volume":"39","author":"Pietropaolo","year":"2025","journal-title":"J Endourol"},{"key":"R2-20260713","doi-asserted-by":"crossref","first-page":"102924","DOI":"10.1016\/j.eclinm.2024.102924","volume":"78","year":"2024","journal-title":"EClinicalMedicine"},{"key":"R3-20260713","doi-asserted-by":"crossref","first-page":"535","DOI":"10.7326\/0003-4819-158-7-201304020-00005","article-title":"Medical management to prevent recurrent nephrolithiasis in adults: A systematic review for an American College of Physicians Clinical guideline","volume":"158","author":"Fink","year":"2013","journal-title":"Ann Intern Med"},{"key":"R4-20260713","doi-asserted-by":"crossref","first-page":"s1084","DOI":"10.2741\/1119","article-title":"Citrate and mineral metabolism: Kidney stones and bone disease","volume":"8","author":"Caudarella","year":"2003","journal-title":"Front Biosci"},{"key":"R5-20260713","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1172\/JCI119051","article-title":"Adenosine triphosphate citrate lyase mediates hypocitraturia in rats","volume":"98","author":"Melnick","year":"1996","journal-title":"J Clin Invest"},{"key":"R6-20260713","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrneph.2016.101","article-title":"Idiopathic hypercalciuria and formation of calcium renal stones","volume":"12","author":"Coe","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"R7-20260713","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000070134","article-title":"Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: Is there any difference?","volume":"70","author":"Tefekli","year":"2003","journal-title":"Urol Int"},{"key":"R8-20260713","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0022-5347(17)35888-3","article-title":"Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis","volume":"150","author":"Barcelo","year":"1993","journal-title":"J Urol"},{"key":"R9-20260713","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1759-8893.2011.00046.x","article-title":"Cost-effectiveness of the preventive treatment of urolithiasis with potassium citrate","volume":"2","author":"Bola\u00f1os-D\u00edaz","year":"2011","journal-title":"J Pharm Health Serv Res"},{"key":"R10-20260713","doi-asserted-by":"crossref","first-page":"E1060","DOI":"10.1111\/j.1464-410X.2012.11212.x","article-title":"Primary prevention of nephrolithiasis is cost-effective for a national healthcare system","volume":"110","author":"Lotan","year":"2012","journal-title":"BJU Int"},{"key":"R11-20260713","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0022-5347(05)64546-6","article-title":"When is medical prophylaxis cost-effective for recurrent calcium stones?","volume":"168","author":"Chandhoke","year":"2002","journal-title":"J Urol"},{"key":"R12-20260713","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/UPJ.0000000000000300","article-title":"Pharmaceutical versus over-the-counter potassium citrate: A benchtop comparison","volume":"9","author":"Wong","year":"2022","journal-title":"Urol Pract"},{"key":"R13-20260713","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-5347(17)46962-X","article-title":"Long-term treatment of calcium nephrolithiasis with potassium citrate","volume":"134","author":"Pak","year":"1985","journal-title":"J Urol"},{"key":"R14-20260713","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/S0022-5347(01)68155-2","article-title":"Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis","volume":"158","author":"Ettinger","year":"1997","journal-title":"J Urol"},{"key":"R15-20260713","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1089\/end.2019.0040","article-title":"Long-term adherence to medications in secondary prevention of urinary tract stones","volume":"33","author":"Golomb","year":"2019","journal-title":"J Endourol"},{"key":"R16-20260713","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/ki.2012.419","article-title":"Emergency department visits, use of imaging, and drugs for urolithiasis have increased in the United States","volume":"83","author":"Fwu","year":"2013","journal-title":"Kidney Int"},{"key":"R17-20260713","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1056\/NEJMoa1404446","article-title":"Ultrasonography versus computed tomography for suspected nephrolithiasis","volume":"371","author":"Smith-Bindman","year":"2014","journal-title":"N Engl J Med"},{"key":"R19-20260713","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldq033","article-title":"Health outcomes in economic evaluation: The QALY and utilities","volume":"96","author":"Whitehead","year":"2010","journal-title":"Br Med Bull"},{"key":"R20-20260713","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.urology.2010.12.073","article-title":"Decreasing the cost of flexible ureterorenoscopic procedures","volume":"78","author":"Somani","year":"2011","journal-title":"Urology"},{"key":"R21-20260713","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.urology.2013.12.019","article-title":"Decreasing cost of flexible ureterorenoscopy: Single-use laser fiber cost analysis","volume":"83","author":"Chapman","year":"2014","journal-title":"Urology"}],"container-title":["Urology Annals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ua.ua_37_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:00:18Z","timestamp":1783947618000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.4103\/ua.ua_37_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ua.ua_37_26","relation":{},"ISSN":["0974-7796","0974-7834"],"issn-type":[{"value":"0974-7796","type":"print"},{"value":"0974-7834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2026-03-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}